HongShan reports portfolio rights acquisition and drug-development partnerships

January portfolio update reports AbelZeta’s January 16 agreement with AstraZeneca concerning C-CAR031 rights, Insilico Medicine’s January 27 agreement with Qilu, and XtalPi’s January 26 strategic agreement with Guangdong HEC Pharmaceutical. Proposed joint venture and contingent milestone consideration are not treated as completed investment or cash received.